0
0

Safe Step Act

3/8/2024, 8:15 AM

Summary of Bill HR 2630

The Safe Step Act, also known as Bill 118 hr 2630, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to address the issue of step therapy, which is a practice used by insurance companies to require patients to try and fail on lower-cost medications before they can receive coverage for the medication prescribed by their healthcare provider.

The Safe Step Act aims to protect patients by establishing guidelines for step therapy protocols. It requires insurance companies to implement a clear and transparent process for requesting exceptions to step therapy requirements. This process must be based on clinical guidelines and take into account the individual needs of the patient.

Additionally, the bill requires insurance companies to respond to these exception requests in a timely manner, ensuring that patients are not left waiting for necessary medications. It also allows for expedited review in cases where a delay in treatment could cause harm to the patient. Overall, the Safe Step Act seeks to prioritize the health and well-being of patients by ensuring that they have timely access to the medications prescribed by their healthcare providers. This legislation has garnered bipartisan support and is seen as a positive step towards improving patient care in the United States.

Congressional Summary of HR 2630

Safe Step Act

This bill requires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer. 

A request for such an exception to the protocol must be granted if (1) an otherwise required treatment has been ineffective, (2) such treatment is expected to be ineffective and delaying effective treatment would lead to irreversible consequences, (3) such treatment will cause or is likely to cause an adverse reaction to the individual, (4) such treatment is expected to prevent the individual from performing daily activities or occupational responsibilities, (5) the individual is stable based on the prescription drugs already selected, or (6) there are other circumstances as determined by the Employee Benefits Security Administration.

The bill requires a group health plan to implement and make readily available a clear process for an individual to request an exception to the protocol, including required information and criteria for granting an exception. The bill further specifies timelines under which plans must respond to such requests.

Current Status of Bill HR 2630

Bill HR 2630 is currently in the status of Bill Introduced since April 13, 2023. Bill HR 2630 was introduced during Congress 118 and was introduced to the House on April 13, 2023.  Bill HR 2630's most recent activity was Referred to the House Committee on Education and the Workforce. as of April 13, 2023

Bipartisan Support of Bill HR 2630

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
344
Democrat Cosponsors
214
Republican Cosponsors
130
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 2630

Primary Policy Focus

Health

Potential Impact Areas

- Drug therapy
- Employee benefits and pensions
- Health care costs and insurance
- Health care coverage and access
- Prescription drugs

Alternate Title(s) of Bill HR 2630

Safe Step Act
Safe Step Act
To amend the Employee Retirement Income Security Act of 1974 to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes.

Comments

Latest Bills

Providing amounts for the expenses of the Committee on Ethics in the One Hundred Nineteenth Congress.
Bill HRES 131December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Central Yukon Record of Decision and Approved Resource Management Plan".
Bill HJRES 106December 12, 2025
Expressing the sense of the House of Representatives in condemning the Government of the People's Republic of China for its harassment and efforts to intimidate American citizens and other individuals on United States soil with the goal of suppressing speech and narratives the People's Republic of China finds unwelcome.
Bill HRES 130December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "North Dakota Field Office Record of Decision and Approved Resource Management Plan".
Bill HJRES 105December 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Land Management relating to "Miles City Field Office Record of Decision and Approved Resource Management Plan Amendment".
Bill HJRES 104December 12, 2025
Providing amounts for the expenses of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party in the One Hundred Nineteenth Congress.
Bill HRES 104December 12, 2025
Critical Access for Veterans Care Act
Bill S 1868December 12, 2025
OATH Act of 2025
Bill S 1665December 12, 2025
A bill to extend the authority for modifications to the Second Division Memorial in the District of Columbia.
Bill S 1353December 12, 2025
Saving Our Veterans Lives Act of 2025
Bill S 926December 12, 2025
Safe Step Act
Bill S 652March 12, 2024
Pharmacy Benefit Manager Reform Act
Bill S 1339December 15, 2023